Efficacy and tolerability of rituximab-based chemotherapy in CD20-positive non-Hodgkin lymphoma (NHL)

被引：0
|
作者：
Polakiewicz-Gilowska, A. [1 ]
Cedrych, I. [1 ]
Nowara, E. [1 ]
机构：
[1] M Sklodowska Curie Mem Canc Ctr, Gliwice, Poland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.19542
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19542
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and tolerability of rituximab-based chemotherapy in CD20 positive non-Hodgkin lymphoma
    Cedrych, I.
    Polakiewicz-Gilowska, A.
    Nowara, E.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 246 - 246
  • [2] Rituximab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin's lymphoma and HIV infection
    Spina, M
    Sparano, JA
    Jaeger, U
    Rossi, G
    Tirelli, U
    [J]. AIDS, 2003, 17 (01) : 137 - 138
  • [3] Paraneoplastic pemphigus associated with CD20-positive follicular non-Hodgkin's lymphoma treated with rituximab: a third case resistant to rituximab therapy
    Hoque, S. R.
    Black, M. M.
    Cliff, S.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (02) : 172 - 175
  • [4] Position paper on the therapeutic use of rituximab in CD20-positive diffuse large B-cell non-Hodgkin's lymphoma
    Pettengell, R
    Linch, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (01) : 44 - 48
  • [5] Pneumocystis jirovecii pneumonia in non-Hodgkin's lymphoma after rituximab-based chemotherapy: a case series
    Zhang, Qianying
    Han, Liang
    Lin, Yuanyuan
    Sun, Xiaohong
    Ye, Haige
    Qian, Honglan
    Sun, Lan
    Jiang, Songfu
    Liang, Bin
    [J]. TRANSLATIONAL CANCER RESEARCH, 2022, 11 (07) : 2291 - 2298
  • [6] CHOP chemotherapy with rituximab in DLBCL non-Hodgkin's lymphoma (NHL) - Our experience
    Utracka-Hutka, B
    Cedrych, I
    Polakiewicz-Gilowska, A
    Szelc, S
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 178 - 178
  • [7] Obinutuzumab in Combination with Chemotherapy Enhances Direct Cell Death in CD20-Positive Obinutuzumab-resistant Non-Hodgkin Lymphoma Cells
    Fujimura, Takaaki
    Yamashita-Kashima, Yoriko
    Kawasaki, Natsumi
    Yoshiura, Shigeki
    Harada, Naoki
    Yoshimura, Yasushi
    [J]. MOLECULAR CANCER THERAPEUTICS, 2021, 20 (06) : 1133 - 1141
  • [8] CHEMOTHERAPY OF HUMAN NON-HODGKIN LYMPHOMA (NHL) XENOGRAFTS
    KOPPER, L
    NAGY, P
    MAGYAROSY, E
    MAJOR, J
    [J]. ACTA MORPHOLOGICA HUNGARICA, 1986, 34 (04): : 289 - 297
  • [9] Phase Ib study combining ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with CD20-positive B-cell non-Hodgkin lymphoma (NHL)
    Younes, Anas
    Flinn, Ian
    Berdeja, Jesus G.
    Friedberg, Jonathan W.
    Alberti, Sara
    Thieblemont, Catherine
    Morschhauser, Franck
    Hellemans, Peter
    Hall, Brett
    Smit, Johan
    Skee, Donna
    de Vries, Ronald
    Todorovic, Marija
    Khan, Imran
    Fourneau, Nele
    Oki, Yasuhiro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Platelet and leukocyte-derived microparticles and procoagulant activity during rituximab-based chemotherapy in patients with non-Hodgkin lymphoma
    Koska, A.
    Ford, I.
    Asghar, S.
    Untiveros, P.
    Culligan, D.
    Watson, H.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 : 50 - 50
12345